30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
On May 1, 2020, the City of Philadelphia allowed certain construction projects to resume. By an Exe...
Read More >
Minnesota’s wage theft law, which largely went into effect on July 1, 2019, created new documentati...
Read More >
Seyfarth Synopsis: In two months (on March 31, 2020), the window closes for 403(b) plan sponsors to ...
Read More >
On Dec. 13, 2019, the National Labor Relations Board (NLRB) released a series of new regulations int...
Read More >
Obermayer is excited to introduce its new “GovCon Examiner Live” webinar series, your resource fo...
Read More >
No job is finished until the paperwork is done, but compliant employers also know that no job is sta...
Read More >